Completed PHASE2 INTERVENTIONAL 4-arm NCT00559871

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease (Fjord)

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose Response Study of the Efficacy, Safety and Tolerability of Fipamezole as an Oromucosal Fast Dissolving Tablet in the Treatment of Parkinson's Disease Patients.

Sponsor: Juvantia Pharma Ltd

Conditions Parkinson's Disease

Interventions fipamezole

Updated 9 times since 2017 Last updated: Jun 2, 2009 Started: Oct 31, 2007 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00559871, this PHASE2 trial focuses on Parkinson's Disease and remains completed. Sponsored by Juvantia Pharma Ltd, it has been updated 9 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Mar 2026 — Present [monthly]

Completed PHASE2
Feb 2026 — Mar 2026 [monthly]

Completed PHASE2
Nov 2025 — Feb 2026 [monthly]

Completed PHASE2
Sep 2024 — Nov 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Juvantia Pharma Ltd
Santhera Pharmaceuticals

Data source: Juvantia Pharma Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ahmedabad, India , Atlanta, United States , Augusta, United States , Baltimore, United States , Bangalore, India , Birmingham, United States , Boca Raton, United States , Chicago, United States , Durham, United States , Englewood, United States and 24 more locations